Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. May-Jun 2020;10(3):266-270.
doi: 10.1016/j.jceh.2020.04.001. Epub 2020 Apr 3.

Joint Guidance From SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19

Affiliations
Free PMC article
Review

Joint Guidance From SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19

Mathew Philip et al. J Clin Exp Hepatol. .
Free PMC article

Abstract

Coronavirus disease 2019 (COVID-19), which started in December 2019 in China, has resulted in a pandemic leading to significant morbidity and mortality across the globe. Although it mainly causes respiratory symptoms, respiratory failure and death due to multiorgan failure, there is evolving evidence to suggest gastrointestinal (GI) and liver involvement by this virus. Owing to this, health-care professionals taking care of GI and liver diseases are also at an increased risk of getting exposed. Hence, there is a need for protocols to be prepared to guide the handling of COVID-19 patients by the GI and liver specialists, as well as to manage the pre-existing GI and liver diseases during the ongoing pandemic. We present here the guidelines prepared jointly by the three Indian professional bodies in the field of GI diseases, namely the Society of Gastrointestinal Endoscopy of India, Indian Society of Gastroenterology, and Indian National Association for the Study of the Liver.

Keywords: COVID-19; India; endoscopy; guidance; liver.

Conflict of interest statement

The authors have none to declare.

Similar articles

See all similar articles

References

    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Gu J., Han B., Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.02.054. pii: S0016-5085(20)30281-X. - DOI - PMC - PubMed
    1. Xiao F., Tang M., Zheng X. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.02.055. pii: S0016-5085(20)30282-1. - DOI - PMC - PubMed
    1. Zhang C., SHi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/s2468-1253(20)30057-1. - DOI - PMC - PubMed
    1. Government of India, Ministry of Health & Family Welfare, Directorate General of Health Services (EMR Division) Guidelines on Clinical Management of COVID-19. https://www.mohfw.gov.in/pdf/GuidelinesonClinicalManagementofCOVID1912020.pdf Published 1 March 2020. Available from:
Feedback